pujasari neoplasia week 3
TRANSCRIPT
-
7/23/2019 Pujasari Neoplasia Week 3
1/42
NEOPLASIA
Hening P. Syahrin
Basic Science and Fundamental of Nursing GroupFaculty of Nursing Universitas Indonesia
2008
PDFCreatedwith
deskPDFPDFWrite
r-Trial::http://www
.docudesk.com
http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/ -
7/23/2019 Pujasari Neoplasia Week 3
2/42
Sub topics to cover today
The concepts of cell growth &
differentiation
Characteristics of benign & malign
neoplasm Carcinogenesis & cause of cancer
PDFCreatedwith
deskPDFPDFWrite
r-Trial::http://www
.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
3/42
Cancer is the 2nd leading cause of death in US
after cardiovascular disease
affects all age groups, any organ, female& male
most common site in maleprostate, in
femalebreast results from altered cell differentiation &
growth
its cell growth is uncoordinated &relatively autonomous
is not a single disease
PDFCreatedwith
deskPDFPDFWrite
r-Trial::http://www
.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
4/42
DefinitionNeoplasia: neo (new) + plasia (form)
the process of new growth
Neoplasm: the new growth; can be benign ormalignant
Tumor= tumere (to swell); historically referred toany swelling, now synonymous with neoplasm
Oncology=oncos (mass, bulk) + logos (reason);the study of neoplasia
Oncogenesis = oncos + genesis (production); the
causation or production of neoplasiaCancer = karkinos (crab) the common term for all
malignant neoplasms (used more frequently in
human)
PDFCreatedwith
deskPDFPDFWrite
r-Trial::http://www
.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
5/42
Definition it is called cancer as it has similar characteristics
with a cancer/crab
eg. adhere in obstinate manner like a crab,infiltrative, erosive growth that extent crab-likefeet
some inconsistencies in classifying & naming
suffix oma is almost always present (fromonkoma = swelling)
naming should indicate benign vs malignant,
mesenchymal vs epithelial plus mixed tumor: contains more than one cell
type but they are derived from one germ layer
PDFCreatedwith
deskPDFPDFWrite
r-Trial::http://www
.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
6/42
Classification & Naming of Neoplasm
Benign
Mesenchymal (structuraltissue, blood vessels,lymphatics)
- lipoma,
- fibroma,- osteoma.
Epithelial:
- pituitary adenoma- hepatocellular adenoma
Malignant
Mesenchymal:
- liposarcoma,
- fibrosarcoma,
- osteosarcoma
Epithelial:
- pituitary carcinoma- hepatocellular carcinoma
PDFCreatedwith
deskPDFPDFWrite
r-Trial::http://www
.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
7/42assificatio
nofN
eopla
sm
-
7/23/2019 Pujasari Neoplasia Week 3
8/42assificatio
nofN
eopla
sm
-
7/23/2019 Pujasari Neoplasia Week 3
9/42
-
7/23/2019 Pujasari Neoplasia Week 3
10/42
Benign vs Malignant NeoplasmBenign, most benign tumor are: composed of well differentiated cells that closely
resemble their normal counterparts, often
including the same architecture arrangementeg. a uterine leiomyoma resemble uterinesmooth muscle cells
grow as cohesive expansive masses that remainlocalized to their site of origin grow & expand slowly with comprehensive
atrophy of adjacent parenchymal cells & many
have a well-defined fibrous capsule formed fromthe surrounding compressed stroma fail to metastasize to distant sites
PDFCreatedwithdeskPDFPDFWrite
r-Trial::http://www
.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
11/42
Benign vs Malignant Neoplasm
Benign, some benign tumor:
are spontaneously regressed
may slowly progress to malignancy
morphologically, may have serious, if not
fatal, consequencesegs. tumors of brains (space-occupyinglesions), some hormone-producing tumors
(tumor of pancreatic islet cells thatproduces insulin, causing hypoglycemia)
PDFCreatedwithdeskPDFPDFWrite
r-Trial::http://www
.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
12/42
Benign vs Malignant Neoplasm
Malignant tumors
an aggressive & life-threatening tumor
characterized by:1) anaplasia,
2) rapid rate of growth,
3) local invasion of tissue, &
4) metastasis.
there are: 1) solid tumors & 2) hematologiccancers
PDFCreatedwithdeskPDFPDFWriter-Trial::http://www.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
13/42
1) Differentiation/Anaplasia anaplasia (loss of differentiation)
characterized malignancy
morphology anaplasia includes:
a) pleomorphism: variation insize & shape both cells(anisocytosis) & nuclei
(anisokaryosis)b) abnormal nuclei: large,coarsely clumped, marginalizedchromatin
c) mitoses: increased, tripolar
mitotic figured) loss of polarity: no a polarizedorientation
e) single large nucleus/
binucleated/ multinucleated
PDFCreatedwithdeskPDFPDFWriter-Trial::http://www.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
14/42
2) Rate of Growth (Tumor Cell Kinetics)
most malignant tumors grow rapidly than benignones
the rate of tissue growth depends on 3 factors:increased number of cells that are dividing, cellsdo not die on schedule, greater ratio of dividing
cells and resting cells (growth fraction), &decreased length of time taken for total mass ofcells to double (doubling time/Td)
alteratered in contact inhibition (the cessation ofgrowth after a cell comes in contact with another
cell).
PDFCreatedwithdeskPDFPDFWriter-Trial::http://www.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
15/42
CellCycle
-
7/23/2019 Pujasari Neoplasia Week 3
16/42
3) Local Invasion of Tissue
extensive infiltration (invasion) & destruction ofsurrounding tissues
besides metastasis, invasion is the most reliableindicator of malignancy
can make complete surgical removal difficult
(often necessitates taking wide margins) seeding of the cancer cells into body cavities
occurs when tumor erodes these spaces
tumor cells secret tumor-angiogenesis factors,which enables the development of new bloodvessels within tumor (angiogenesis)
PDFCreatedwithdeskPDFPDFWriter-Trial::http://www.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
17/42
4) Metastasis as a development of secondary tumor in a location
distant from primary tumor
indicates malignancy and is what kills the majority ofhuman cancer patients
metastatic tumor retains characteristics of the primarytumor from which they were derived possible todetermine the site of primary tumor from the cellularcharacteristics of the metastatic tumor
occasionally, the metastatic tumor is far advanced beforethe primary tumor becomes clinically detected
eg. tumor of the kidney is completely
undetected/asymptomatic even when a metastatic lesionis found in the lung
there is selectivity in organ metastasis, eg. Heart, skin &skeletal muscle are rarely as a site of metastasis
PDFCreatedwithdeskPDFPDFWriter-Trial::http://www.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
18/42
-
7/23/2019 Pujasari Neoplasia Week 3
19/42
Tu
morMetas
tasis
-
7/23/2019 Pujasari Neoplasia Week 3
20/42
gnv
sMalignan
tNeo
plasm
-
7/23/2019 Pujasari Neoplasia Week 3
21/42
Carcinogenic agents
1. Chemical carcinogens
2. Oncogenic viruses
3. Radiation carcinogenesis
4. Chronic inflammation5. (heredity)
PDFCreatedwithd
eskPDFPDFWriter-Trial::http://www.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
22/42
Chemical Carcinogens 2-4% cancer death are associated with an exposure to
an occupational hazard
egs. asbestos fiberrisks of lung, laryngeal, & GI Ca;
benzenaleukemia; herbicidenon-Hodgkinslymphoma
many Ca are associated with lifestyle; smoking, diet,alcohol consumption
egs. cigarette smoke contains procarcinogen &promoterrisk of lung & laryngeal cancers
diet contains polycyclic hydrocarbons (from smokedmeat/fish or multiple reused oil), nitrosamines (from
food/vegetables preservative), high fat & protein but lowfibers
the effect of carcinogenic agents is dose & durationdependent. eg. duration 5-30 years after exposure.
PDFCreatedwithd
eskPDFPDFWriter-Trial::http://www.
docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
23/42
-
7/23/2019 Pujasari Neoplasia Week 3
24/42
-
7/23/2019 Pujasari Neoplasia Week 3
25/42
Oncogenic Virusesan oncogenic virus is
one that can inducecancer
virus enters a host cell,
incorporates into hostcell DNA, & takescontrol of the cellular
machinery for thepurpose of producingviral proteins
PDFCreatedwithd
eskPDFPDFWriter
-Trial::http://www.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
26/42
-
7/23/2019 Pujasari Neoplasia Week 3
27/42
Radiation Carcinogenesis
through the effect of ionizing radiation
egs in atomic bomb survivor, patients
diagnostically exposed, industrial workers,lab scientistmalignant epitheliomas ofskin & leukemia
the effect depends on dose, sex, age atexposure
sunlightskin cancer, primarily in the area
that frequently exposed; head, neck, &arms, higher incident in individual with lackof UV filtering skin pigment melanin
PDFCreatedwithd
eskPDFPDFWriter
-Trial::http://www.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
28/42
-
7/23/2019 Pujasari Neoplasia Week 3
29/42
Chronic Inflammation the generation of O2 free radicals by
inflammatory cells,
the regeneration of cells to replacedamaged cells at a site of chronicinflammation may result in geneticdamage progress to neoplastictransformation
proliferating fibroblast at the chronicinflammation can secrete growth factorsthat contribute to neoplastic transformation
PDFCreatedwithd
eskPDFPDFWriter
-Trial::http://www.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
30/42
Heredity there is a genetic predisposition for development
of cancers ( 50 type of cancers)
eg. Breast cancer occurs more frequently in women whose
grandmothers, mothers, aunts, & sisters with breast malignancy
the risk increases 50% in women age 65 whohave multiple family members with breast cancer
2 oncongens: BRCA1 &BRCA2 have beenimplicated in a genetic susceptibility to breastcancer
mutation of p53 tumor suppressor gene placeswomen at high risk of breast cancer in 20 or 30of age
40% of retinoblastoma is inherited
PDFCreatedwithd
eskPDFPDFWriter
-Trial::http://www.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
31/42
Carcinogenesis & Cause of Cancer
as cancer is not a single diseaseit doesnot have a single cause
occurs because interaction between multiplerisks factors (carcinogen & heredity) orrepeated exposure to a single
carcinogenic agentall cancers result from nonlethal genetic
changes that transform a normal cell intocancerous cell
PDFCreatedwithd
eskPDFPDFWriter
-Trial::http://www.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
32/42
-
7/23/2019 Pujasari Neoplasia Week 3
33/42
Carsinogensis/Oncogenesisis a genetic mechanism whereby normal cells are
transformed into cancer cells
two kinds of gene control normal cell growth & replication:
1. growth-promoting regulatory genesprotooncogens2. growth-inhibiting regulatory genesanti-oncogenes
(cancer supressor genes)
these genes have been implicated as principal targets of
genetic damage that occurs during the development ofcancer cell
oncogenes are mutations of normal growth-regulatinggenes
the mutation of cause proto-oncogen to change intooncogen results in unregulated cellular proliferation
PDFCreatedwithd
eskPDFPDFWriter
-Trial::http://www.docudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
34/42
Onco
genesis
-
7/23/2019 Pujasari Neoplasia Week 3
35/42
Multiple Steps of Oncogenesis
Transformation of normal cells into cancer cells bycarcinogenic agents is a multiple process, 3 stages:
1. initiation: the exposure of cells to appropriate doses of acarcinogenic agent that makes them susceptible to
malignant transformationirreversible changes in thegenome
2. Promotion: induction of unregulated accelerated growthin already initiated cells by various chemical & growth
factorsreversible if the promoter substance isremoved
3. Progression: the process whereby tumor cells acquiredmalignant phenotypic changes that allow invasiveness,metastatic competency, a tendency for autonomousgrowth, & increased karyotypic instability
PDFCreatedwithdeskPDFPDFWriter
-Trial::http://www.d
ocudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
36/42
Seven Cellular Traits in Neoplasm
1. activation of oncogenesis
2. inactivation of tumor suppressor gen
3. evasion of apoptosis
4. defects in DNA repair5. limitless replicative potential
6. sustained angiogenesis
7. ability to invade and metastasize
PDFCreatedwithdeskPDFPDFWriter
-Trial::http://www.d
ocudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
37/42
CellularTra
itsinN
eopla
sm
-
7/23/2019 Pujasari Neoplasia Week 3
38/42
Systemic/General Effects of Neoplasm1. impairment of function at the primary site of involvement, caused bydestruction & replacement of parenchymal tissue by neoplastic
growth, eg. lung cancer will impair respiratory function,
as the tumor grows & metastasizes, other body structures become
affected2. compression of adjacent vital structures
the growth of brain tumor can compress adjacent vital structure3. bleeding & hemorrhage, related to compression of blood vessel
eg. colorectal cancer--blood in the stool
4. obstruction of hollow viscera & rupture of tubular organ as a result ofexpansive growth of tumor with compression & invasion
5. ulceration, necrosis & infection of tumor area, related to ischemiaassociated with rapid growth, with subsequent bacterial infection
cancers may produce enzymes & metabolic toxins that destructsurrounding tissues
PDFCreatedwithdeskPDFPDFWriter
-Trial::http://www.d
ocudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
39/42
Systemic/General Effects of Neoplasm6. effusion in serous cavity, due to impaired lymph flow or erosion of
tumor into the cavity7. pain (that does not heal is a second warning signal of cancer)--
liberation of pain mediator by the tumor, compression, or ischemia ofthe structure
8. cachexia; lost of muscle mass & fat store as a result from the actionof cytokines (anorexigenic) produced by tumor cell & TNF (TumorNecrosis Factor released by macrophage
9. anemia, caused be bleeding and depression of erythrocytesproduction
10. inappropriate hormone productioneg. uncontrolled corticosteroid production of adrenal cortex tumorproduction of hormone-like substances that are not regulated bynormal feedback mechanisms
11. paraneoplastic syndromes; manifestation in sites that are nor
directly affected by disease.eg. cancer may produce procoagulation factors that contribute toincreased risk of venous thrombosis
PDFCreatedwithdeskPDFPDFWriter-Trial::http://www.d
ocudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
40/42
Staging & Grading of Tumors
Two basic methods of classifying cancer are:1. staging according to clinical stage of the disease, &2. grading according to histologic & cellular
characteristics of tumors.Both methods are useful to determine the course of the
disease & to aid in selecting appropriate treatments
1. Staging to determine progress & spread classify tumors based according to their progression
TNM system is based on:- assessment of the size of the primary tumor (T)- involvement of regional lymph nodes (N)- presence or absence of distant metastasis (M)
PDFCreatedwithdeskPDFPDFWriter-Trial::http://www.d
ocudesk.com
-
7/23/2019 Pujasari Neoplasia Week 3
41/42
-
7/23/2019 Pujasari Neoplasia Week 3
42/42
Staging & Grading of Tumors
2. Grading to determine level of differentiation & number of
mitoses
involves microscopic examination quantify characteristic of tumors as a means of
predicting their outcomes:- degree of differentiation
- size of nuclei- mitotic activity- degree of vascularization
- presence or absence of necrosis cancers classified as grade I, II, III, & IV with increasing
anaplasia & lack of differentiation
PDFCreatedwithdeskPDFPDFWriter-Trial::http://www.d
ocudesk.com